John Kiely, Director at Amneal Pharmaceuticals, Inc. (AMRX), sold 50,000 shares at $7.59 ($380K) on 2025-05-12, disclosed to the SEC on 2025-05-13.
Seasonal sale ($380k) by Director — this insider has traded AMRX in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| AMRX | SELL | 2024-11-26 | $286K | — | Filing → |
| ZVO | BUY | 2020-09-10 | $43K | — | Filing → |
| AMRX | BUY | 2020-05-19 | $44K | — | Filing → |